Dear Doctor,
Add more life to their years,
As Sacuhart reduces hospitalisation and
mortality risk
Sacuhart Lowers Re-hospitalisation with
21% RRR when switched from ACEi and
upto 44% in ADHF vs ACEi
Sacuhart Lowers Risk of CV death with
upto 20% RRR when switched from ACEi
and upto 34% in ADHF vs ACEi
00:33
Dear Doctor, once HF is ascertained with
ECHO and NT-ProBNP.
Start SACUHART in HFrEF as replacement
for ACEi/ARB and in De Novo HFrEF
(ACEi/ARB Naive)
When the patient is stable in OPD or IPD
Doctor start SACUHART 50mg BID or 100mg BID
and titrate up at 2-4 weeks gap to maximum
tolerated dose of 200 mg BID
Doctor, SACUHART to be consumed with or
without food
01:09
Doctor your reliance on our quality won’t fail
Doctor for Sacuhart, Molar Ratio is 1:1 and
is formulated in amorphous anionic form
Doctor in SACUHART, graph of Valsartan and
Sacubitril clearly shows that Sacuhart is
bioequivalent to international standard and its
amorphous form matches Co-Crystal form
Doctor Sacuhart is self manufactured by Macleods
01:38
Doctor,
Promise to secure the failing Hearts
Please prescribe in every HFrEF patient, SACUHART and
secure the failing heart
As they still have more to live